Y Intercept Hong Kong Ltd Has $3.08 Million Holdings in Danaher Corporation $DHR

Y Intercept Hong Kong Ltd raised its position in Danaher Corporation (NYSE:DHR) by 445.3% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 15,573 shares of the conglomerate’s stock after acquiring an additional 12,717 shares during the period. Y Intercept Hong Kong Ltd’s holdings in Danaher were worth $3,076,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently added to or reduced their stakes in DHR. Sierra Ocean LLC grew its stake in Danaher by 116.9% in the first quarter. Sierra Ocean LLC now owns 141 shares of the conglomerate’s stock valued at $29,000 after acquiring an additional 76 shares during the period. Red Tortoise LLC grew its stake in Danaher by 175.0% in the second quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock valued at $30,000 after acquiring an additional 98 shares during the period. Smallwood Wealth Investment Management LLC acquired a new stake in Danaher in the first quarter valued at approximately $31,000. Ramirez Asset Management Inc. acquired a new stake in Danaher in the second quarter valued at approximately $40,000. Finally, Costello Asset Management INC acquired a new stake in Danaher in the first quarter valued at approximately $41,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Analyst Upgrades and Downgrades

DHR has been the topic of several analyst reports. Rothschild & Co Redburn reaffirmed a “neutral” rating and set a $220.00 target price (down previously from $245.00) on shares of Danaher in a research report on Wednesday, October 8th. Redburn Partners set a $220.00 target price on Danaher in a research report on Wednesday, October 8th. Bank of America cut their target price on Danaher from $230.00 to $220.00 and set a “buy” rating on the stock in a research report on Monday, September 22nd. Guggenheim reaffirmed a “buy” rating and set a $250.00 target price on shares of Danaher in a research report on Wednesday, July 23rd. Finally, Rothschild Redb cut Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Eighteen investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $243.39.

Danaher Stock Performance

Shares of Danaher stock opened at $213.99 on Thursday. The business’s fifty day simple moving average is $203.12 and its 200 day simple moving average is $199.20. The firm has a market capitalization of $151.15 billion, a P/E ratio of 44.12, a price-to-earnings-growth ratio of 3.32 and a beta of 0.77. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $258.23. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, topping analysts’ consensus estimates of $1.72 by $0.17. The business had revenue of $6.05 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s quarterly revenue was up 4.4% compared to the same quarter last year. During the same period last year, the company posted $1.71 earnings per share. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, September 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio (DPR) is 26.39%.

Insider Buying and Selling

In related news, Director Teri List sold 2,778 shares of Danaher stock in a transaction on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Company insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.